相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Towards precision medicine for AML
Hartmut Dohner et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia
Noortje van Gils et al.
FRONTIERS IN ONCOLOGY (2021)
Herbal melanin induces interleukin-1β secretion and production by human THP-1 monocytes via Toll-like receptor 2 and p38 MAPK activation
Adila El-Obeid et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Effect of MiR-210 on the Chemosensitivity of Breast Cancer by Regulating JAK-STAT Signaling Pathway
Zeyu Xing et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
Paul Dowling et al.
PROTEOMES (2021)
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
C. D. DiNardo et al.
BLOOD (2020)
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
Zdravka Medarova et al.
SCIENTIFIC REPORTS (2020)
Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
Fatemeh Pourrajab et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Treatment of Relapsed Acute Myeloid Leukemia
Felicitas Thol et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression
Haiming Ma et al.
ONCOTARGETS AND THERAPY (2020)
Anti-Proliferative and Pro-Apoptotic Effects of Calligonum comosum (L'Her.) Methanolic Extract in Human Triple-Negative MDA-MB-231 Breast Cancer Cells
Zeyad Alehaideb et al.
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE (2020)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Hui Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Mechanisms of drug resistance in acute myeloid leukemia
Jing Zhang et al.
ONCOTARGETS AND THERAPY (2019)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
Yan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The burden of leukemia in the Kingdom of Saudi Arabia: 15years period (1999-2013)
Amen Bawazir et al.
BMC CANCER (2019)
Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia
Kent T. J. Chen et al.
PHARMACEUTICAL RESEARCH (2019)
Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase
Xinzhi Wang et al.
REDOX BIOLOGY (2019)
Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies
Luiza Handschuh
JOURNAL OF ONCOLOGY (2019)
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Cornelia Braicu et al.
CANCERS (2019)
Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB
Masanobu Tsubaki et al.
LABORATORY INVESTIGATION (2019)
Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis
Kubra Karagoz et al.
EBIOMEDICINE (2019)
MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Julia Slotta-Huspenina et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Hai Wang et al.
NATURE COMMUNICATIONS (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
Emilia L. Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer
Isabelle Bar et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway
Dong Ren et al.
MOLECULAR CANCER (2017)
N-acetylcysteine induces apoptosis via the mitochondria-dependent pathway but not via endoplasmic reticulum stress in H9c2 cells
Yuyong Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Expression of embryonic stem cell markers in acute myeloid leukemia
Tiphanie Picot et al.
TUMOR BIOLOGY (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML)
Yongfang Jiang et al.
MEDICAL SCIENCE MONITOR (2017)
microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
Martino Marco Gabra et al.
FRONTIERS IN ONCOLOGY (2017)
CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation
Sabine Matou-Nasri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
Xiaoqiong Tang et al.
MEDICAL SCIENCE MONITOR (2016)
Expression of MIF and CD74 in leukemic cell lines: correlation to DR expression destiny
Mirella Georgouli et al.
BIOLOGICAL CHEMISTRY (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Mi Hee Park et al.
CELLS (2016)
Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia
Li Liu et al.
DIAGNOSTIC PATHOLOGY (2015)
Phenotypic and Functional Analysis of HL-60 Cells Used in Opsonophagocytic-Killing Assay for Streptococcus pneumoniae
Kyung-Hyo Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
MicroRNA-328 directly targets p21-activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity
Chunhui Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia
Jorge Organista-Nava et al.
ONCOLOGY REPORTS (2015)
Broad targeting of resistance to apoptosis in cancer
Ramzi M. Mohammad et al.
SEMINARS IN CANCER BIOLOGY (2015)
Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines
A. A. Mahbub et al.
CELL DEATH & DISEASE (2015)
Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target
Jianbiao Zhou et al.
ONCOTARGET (2015)
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas
Shun-Fa Yang et al.
ONCOTARGET (2015)
Multidrug resistance in relapsed acute myeloid leukemia: Evidence of biological heterogeneity
Chirayu Patel et al.
CANCER (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity
Miaorong She et al.
CANCER LETTERS (2012)
Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation
Cindy Q. Xia et al.
MOLECULAR PHARMACOLOGY (2012)
CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression
Y. Saito et al.
LEUKEMIA (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group
Mark R. Litzow et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
Stephen L. Abrams et al.
CELL CYCLE (2010)
TNF-α- induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL
J. J. Kim et al.
CELL DEATH AND DIFFERENTIATION (2010)
Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
Xianling Guo et al.
BMC CANCER (2008)
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region
Fumihiko Ishikawa et al.
NATURE BIOTECHNOLOGY (2007)
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Eung-Ryoung Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
分享论文
